News Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors Continue Reading Previous InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904Next Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors Related Stories News Why the Most Qualified Candidates Often Perform Worst in Interviews — And How AI Is Changing That News 0G Labs Publishes Verification Framework for Decentralized AI Training as Models Cross 100 Billion Parameters News LadeSofort Launches the Most Comprehensive Platform for Ad-Hoc EV Charging Stations in Germany and Europe News Estate Software Wins Prestigious AI Award News Scytale Expands SOX ITGC Compliance Capabilities Following AudITech Acquisition News Gench Education Announces 2025 Annual Results
